BalchemvsFreeport-McMoRan

BCPC and FCX stock compared: price, dividend, valuation and results, from SEC filings.

Balchem (BCPC) has a market value of $5.2B and Freeport-McMoRan (FCX) $66.1B. Over the last year, with dividends, BCPC moved +8.0% and FCX +12.5%. The P/E is 30.7 for BCPC and 19.2 for FCX. Dividend yield: BCPC none, FCX 1.30%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BCPC$5.2B

    FCX$66.1B

    FCX is 13 times BCPC

  • Revenue, 12 months

    BCPC$1.1B

    FCX$26.4B

    FCX is 24 times BCPC

  • Net income, 12 months

    BCPC$171M

    FCX$3.4B

    FCX is 20 times BCPC

  • Operating margin

    BCPC20.7%

    FCX27.6%

    6.9 points apart

  • ROIC

    BCPC13.8%

    FCX18.0%

    4.2 points apart

  • P/E

    BCPC30.7

    FCX19.2

    BCPC is 1.6 times FCX

  • Dividend yield

    BCPC0.0%

    FCX1.3%

    1.3 points apart

  • 5-year return

    BCPC+0.3%

    FCX+28.8%

    28.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BCPC+0.3%

FCX+28.8%

10015020020222023202420252026
Returns by period
PeriodBCPCWith dividendsFCXWith dividends
1 year since November 19, 2025+8.0%Price +7.4%+12.5%Price +11.5%
3 years since November 20, 2023+34.0%+10.3% a yearPrice +31.8%+30.3%+9.2% a yearPrice +25.5%
5 years since November 19, 2021+0.3%+0.1% a yearPrice -2.3%+28.8%+5.2% a yearPrice +20.1%
10 years since November 21, 2016+119.7%+8.2% a yearPrice +108.4%+252.6%+13.4% a yearPrice +217.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BCPCBalchemFCXFreeport-McMoRan

Valuation

BCPCFCX
Valuation
Price$163.54$45.99
Market value$5.2B$66.1B
Enterprise value (EV)$5.3B$71.2B
P/E30.719.2
P/E, 5-year median41.5–
P/B4.03.2
EV/EBIT23.19.7
Free cash flow yield3.4%2.9%

Results and growth

BCPCFCX
Results and growth
Revenue, 12 months$1.1B$26.4B
Net income, 12 months$171M$3.4B
Free cash flow, 12 months$178M$1.9B
Earnings per share, 12 months$5.31$2.40
Revenue growth, year on year8.8%1.8%
Revenue growth a year, past+8.1%over 5 years+12.8%over 5 years
EPS growth a year, past+12.8%over 5 years–

Margins and returns on capital

BCPCFCX
Margins and returns on capital
Gross margin36.5%28.0%
Operating margin20.7%27.6%
Net margin15.4%13.0%
ROIC13.8%18.0%
ROE13.2%17.5%

Balance sheet

BCPCFCX
Balance sheet
Cash$66M$4.3B
Total debt$142M$10.4B
Net debt / EBITDA0.20.5
Interest cover––

Dividends and buybacks

BCPCFCX
Dividends and buybacks
Dividend yield–1.3%
Dividend per share, 12 months–$0.60
Dividend growth a year, past+11.1%over 5 years–
Buyback yield2.1%0.2%
Shareholder yield2.1%1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BCPC or FCX

Didn't find what you were looking for?

Ask us
Which is bigger, Balchem or Freeport-McMoRan?

By market value, Freeport-McMoRan ($66.1B) is about 12.6 times Balchem ($5.2B), at today's prices.

How did BCPC and FCX stock do over the last 10 years?

Since November 21, 2016, BCPC's price moved +108.4% and FCX's +217.0%. With dividends: BCPC +119.7% (+8.2% a year), FCX +252.6% (+13.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, BCPC or FCX?

The dividend yield at today's price is none for Balchem and 1.30% for Freeport-McMoRan. Over the last twelve months they paid – and $0.60 per share.

What is the P/E of BCPC and FCX?

At today's price, the P/E is 30.7 for BCPC and 19.2 for FCX. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Balchem or Freeport-McMoRan?

Over the last twelve months, the net margin was 15.4% for Balchem and 13.0% for Freeport-McMoRan, and the operating margin 20.7% and 27.6%. Revenue was $1.1B and $26.4B.

Which is the better investment, Balchem or Freeport-McMoRan?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.